Veröffentlichungen Dr. med. Martin Klietz

Veröffentlichungen

Originalpublikationen

  • Depboylu C, Schorlemmer K, Klietz M, Oertel WH, Weihe E, Höglinger GU, Schäfer MK (2011) Upregulation of microglial C1q expression has no effects on
    nigrostriatal dopaminergic injury in the MPTP mouse model of Parkinson disease. J. Neuroimmunol. 236:39-46.
  • Matusch A, Fenn LS, Depboylu C, Klietz M, Strohmer S, McLean JA, Becker JS (2012) Combined elemental and biomolecular mass spectrometry imaging for
    probing the inventory of tissue at a micrometer scale. Anal. Chem. 84: 3170-3178.
  • Schäfer MK, Hartwig NR, Kalmbach N, Klietz M, Anlauf M, Eiden LE, Weihe E (2013) Species-specific vesicular monoamine transporter 2 (VMAT2) expression
    inmammalian pancreatic beta cells: implications for optimising radioligandbased human beta cell mass (BCM) imaging in animal models. Diabetologia
    56:1047-1056.
  • Depboylu C, Klietz M, Maurer L, Oertel WH, Kobayashi K, Weihe E, Höglinger GU, Schäfer MK (2014) Transcriptional and structural plasticity of tyrosine
    hydroxylase expressing neurons in both striatum and nucleus accumbens following dopaminergic denervation. J. Chem. Neuroanatomy 61-62:169-175.
    Keber U, Klietz M, Carlsson T, Oertel WH, Weihe E, Schäfer MK, Höglinger GU, Depboylu C (2015) Striatal tyrosine hydroxylase-positive neurons are associated
    with L-DOPA induced dyskinesia in hemiparkinsonian mice. Neuroscience 298:302-17.
  • Klietz M, Keber U, Carlsson T, Chiu W-H, Höglinger GU, Weihe E, Schäfer M K-H, Depboylu C (2016) L-DOPA-induced dyskinesia is associated with a deficient
    numerical downregulation of striatal tyrosine hydroxylase mRNA-expressing neurons. Neuroscience 331:120-133.
  • Klietz M, Tulke A, Müschen LH, Paracka L, Schrader C, Dressler DW, Wegner F (2018) Impaired Quality of Life and Need for Palliative Care in a German Cohort
    of Advanced Parkinson’s Disease Patients. Front Neurol. 2018 Mar 6;9:120. doi: 10.3389/fneur.2018.00120.

 

Buchkapitel und Übersichtsarbeiten

  • Sussulini A, Matusch A, Klietz M, Bauer A, Depboylu C, Becker JS (2012) Quantitative imaging of Cu, Fe, Mn and Zn in the L-DOPA-treated unilateral 6-
    hydroxydopamine Parkinson’s disease mouse model by LA-ICP-MS. Biomedical Spectroscopy and Imaging 1: 125-136.

 

Abstracts

  • Klietz M, Depboylu C, Höglinger GU, Kobayashi K, Weihe E, Schäfer MK (2011) Phenotypic Traits of Striatal Neurons Expressing Tyrosine Hydroxylase
    and Effects of Nigrostriatal Dopamine Pathway Injury. 7th IBRO Meeting Florence, Italy.
  • Klietz M, Depboylu C, Höglinger, Kobayashi K, Weihe E, M. Schäfer MK (2011) Tyrosine hydroxylase-positive interneurons in mouse striatum express both
    VMAT2 and VIAAT and exhibit plasticity for dynorphin. Neuroscience Abstracts, Washington, D.C., Society for Neuroscience.
  • Klietz M, Keber U, Carlsson T, Chiu W, Schäfer MK, Depboylu C (2012) Striatal Tyrosine Hydroxylase Positive Neurons are Regulated in a Mouse Model of LDOPA
    Induced Dyskinesia 8th FENS Forum of Neuroscience, July 14th-18th, Barcelona, Spain.
  • Klietz M, Depboylu C, Chiu W, Kobayashi K, Weihe E, M. Schäfer MK (2013) Expression analysis of dopaminergic marker genes in tyrosine hydroxylase
    positive neurons in the striatum of TH-eGFP mice by laser microdissection. Abs. T11-12C, Göttingen Meeting of the German Neuroscience Society 2013,
    Göttingen, Germany.
  • Keber U, Klietz M, Oertel WH, Höglinger GU, Carlsson T, Depboylu C (2014) Striatal tyrosine hydroxylase-positive neurons trigger L-DOPA-induced
    dyskinesia in mice. Neurowoche München.
  • Klietz M, Keber U,  Carlsson T,  Höglinger GU,  Schäfer MKH, Weihe E and Depboylu C(2016) L-DOPA-induced dyskinesia is associated with a deficient
    numerical downregulation of striatal tyrosine hydroxylase mRNA-expressing neurons DGN Congress Mannheim, Germany.
  • Klietz M, Tulke A, Müschen LH, Schrader C, Dressler DW, Wegner F (2017) Versorgungssituation und Lebensqualität schwer betroffener
    Parkinsonpatienten unter palliativmedizinischen Aspekten. Deutscher Parkinsonkongress Baden-Baden.
  • Klietz M, Tulke A, Schrader C, Diekstall L, Müschen L, Dressler D, Wegner F (2017) Quality of life and influencing factors in a local population of advanced
    geriatric Parkinson´s Disease patients. Movement Disorder Society 2017 Vancouver.
  • Klietz M, Tulke A, Diekstall L, Müschen L,  Schrader C,  Dressler D,  Wegner F (2017). Palliative care and quality of life in a German cohort of geriatric patients
    with advanced Parkinson´s disease. DGN Congress Leipzig, Germany.
  • Diekstall L, Klietz M, Tulke A, Lange F,  Schrader C, Dressler D, Wegner F (2017). Caregiver burden of relatives from advanced Parkinson’s disease
    patients. DGN Congress Leipzig, Germany.